Professional & Technical Services NY DOL H-1B OSHA ITA

Regeneron Pharmaceuticals, Inc.: H-1B Sponsorship Profile

Regeneron Pharmaceuticals, Inc. in NY (Professional & Technical Services) is a sponsorship-and-safety profile: 51 H-1B LCAs plus an employer-specific OSHA injury record, with no WARN notices in this corpus.

Verify with OSHA → · BLS OEWS →
Regeneron Pharmaceuticals, Inc. workforce trust profile Two rising office-tower pillars encoding federal-records percentiles for the tracks this employer carries. Regeneron Pharmaceuticals, Inc. Federal records · signal DOL H-1B · OSHA ITA 255075100 99 signal 94 signal Hiring Safety 51 filings Grade F
Higher = stronger signal vs. peers (live corpus percentile 0–100 per axis present on this profile). Source: DOL OFLC, OSHA ITA.

Regeneron Pharmaceuticals, Inc. (NY): · 51 H-1B LCAs at a $159,607 disclosed median · OSHA Grade F (DART 0.50)

According to DOL OFLC H-1B disclosures, OSHA ITA injury logs, and state WARN Act notices, Regeneron Pharmaceuticals, Inc. in NY carries 51 H-1B wage filings on record, a $159,607 median wage across 47 disclosed-wage positions (above the $120,000 national median), a weak F OSHA safety grade and no WARN layoff notices on file. H-1B filing volume ranks #510 of 36,919 sponsors in this corpus (about the 99th percentile). Every figure is a federal filing, not an estimate; see methodology for coverage limits.

  • 51 H-1B LCAs
  • $159,607 median wage
  • Grade F OSHA

The record at a glance

According to U.S. Department of Labor, OSHA, and state WARN Act filings, Regeneron Pharmaceuticals, Inc. carries 51 H-1B wage filings on record, a $159,607 median wage across 47 disclosed-wage positions (above the $120,000 national median), a weak F OSHA safety grade and no WARN layoff notices on file. In this corpus, H-1B filing volume ranks #510 of 36,919 sponsors in this corpus (about the 99th percentile), and disclosed median wage sits at the 77th percentile of 178,031 credible H-1B wage rows.

51
H-1B filings
$159,607
median H-1B wage
Grade F
OSHA safety
0
WARN notices

Figures above come from DOL H-1B LCAs and this employer's OSHA injury log; no WARN notices are on file here.

H-1B Filings

51

DOL labor condition applications on file

Median H-1B Salary

$159,607

Across 47 disclosed positions

OSHA Safety Grade

Grade F · DART 0.50

vs 0.27 same 2-digit NAICS sector (OSHA ITA 2022–2023, hours-weighted)

Where Regeneron Pharmaceuticals, Inc.'s H-1B wage sits nationally

Median disclosed wage vs. all US employers with H-1B filings

$159,607 Top 23% higher than 77% of 178,031 US employers

$0–$20,000: 1 US employers (0%). Below this entry. $20,000–$40,000: 341 US employers (0%). Below this entry. $40,000–$60,000: 5,526 US employers (3%). Below this entry. $60,000–$80,000: 16,865 US employers (9%). Below this entry. $80,000–$100,000: 30,954 US employers (17%). Below this entry. $100,000–$120,000: 33,687 US employers (19%). Below this entry. $120,000–$140,000: 28,300 US employers (16%). Below this entry. $140,000–$160,000: 21,256 US employers (12%). This entry sits in this band. $160,000–$180,000: 14,088 US employers (8%). Above this entry. $180,000–$200,000: 9,515 US employers (5%). Above this entry. $200,000–$220,000: 6,376 US employers (4%). Above this entry. $220,000–$240,000: 3,830 US employers (2%). Above this entry. $240,000–$260,000: 2,385 US employers (1%). Above this entry. $260,000–$280,000: 1,542 US employers (1%). Above this entry. $280,000–$300,000: 824 US employers (0%). Above this entry. $300,000–$320,000: 2,541 US employers (1%). Above this entry. Regeneron Pharmaceuticals, Inc. $0 $320,000 every US employer with H-1B filings, bucketed by value

Each bar is a $20K-wide band; taller bars hold more US employers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source DOL Office of Foreign Labor Certification, H-1B Disclosure Data · August 2026

Regeneron Pharmaceuticals, Inc.'s H-1B median wage, FY2024 vs FY2025

$157,800$158,000$158,200$158,400$158,600 FY2024FY2025 $158,469 $157,961 ▼ -0.3%

Filing-count-weighted median across this employer's own disclosed H-1B positions (-0.3% year over year), not a company-wide raise, and not adjusted for role mix changes between years.

Government Data Summary

Field Value Source
Employer Name Regeneron Pharmaceuticals, Inc. DOL OFLC / OSHA
Industry Professional & Technical Services NAICS / DOL
State NY U.S. Federal Records
H-1B Filings 51 DOL OFLC LCA Disclosure
H-1B Median Salary $159,607 DOL OFLC LCA Disclosure
OSHA Safety Grade F OSHA ITA
OSHA DART Rate 0.50 OSHA ITA Establishment Records
Tracks not on file WARN notices Empty by design, not estimated

Regeneron Pharmaceuticals, Inc.'s values above reflect the most recent DOL Labor Condition Applications, OSHA Injury Tracking Application records on file for this employer in NY (Professional & Technical Services).

H-1B Salary Data

Job Title Median
Assoc Dir Biostatistics $225,568
Associate Director CMC Regulatory Affairs $220,000
Assoc Dir Statistical Programming $218,946
Associate Director Data Engineering $217,032
Assoc Dir IT Architect $214,728
Associate Director Product Management $214,141
Associate Director, Service Delivery Management $210,191
Assoc Dir IT Data Management $207,466
Sr Mgr Product Management $205,499
Assoc Dir Service Delivery Management $201,888
Associate Director, Research Program Management $195,188
Senior Manager, CDM Study Lead $190,000
Sr Mgr Biostatistics $184,928
Senior Manager Biostatistics $184,170
Product Manager $180,000
Mgr IT Applications $177,329
Manager, Statistical Programming $175,000
Sr Mgr CDM Study Lead $173,587
Sr Mgr Data Management $173,587
Manager, Biostatistics $173,310
Principal Scientist $172,500
Manager Clinical Study Lead $164,483
Staff Engineer $159,922
Principal Scientist $159,607
Principal Scientist $156,867
Principal Scientist $155,806
Sr Scientist-Bioinformatics $151,693
Principal Biostatistician $148,393
Mgr Supply Structures $147,805
Assoc Mgr CDM Study Lead $147,734
Principal IT Applications Analyst $147,151
Principal Statistical Programmer $145,548
Senior Scientist $145,000
Senior Data Manager $144,219
Senior Statistical Programmer $135,000
Lead IT QA & Compliance Analyst $127,018
Principal DP MSAT Engineer $125,000
Scientist $116,358
Scientist-Assay Development $116,172
Sr Process Controls & Validation Scientist $105,000
Sr. Cleanroom & HEPA Certification Specialist $101,966
Sr. Associate Scientist $101,447
Sr Assoc Scientist $101,295
Senior Associate Scientist $95,000
Associate Scientist $87,032
Associate Scientist $84,455
Associate Scientist $84,455

What the Data Says About Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc. operating in NY within the Professional & Technical Services sector: the company has filed 51 H-1B labor condition applications, of which 47 disclose a usable wage figure with a median of $159,607. Records here combine U.S. Department of Labor disclosures and state workforce agency filings.

On workplace safety, Regeneron Pharmaceuticals, Inc. posted a DART (Days Away, Restricted, Transferred) rate of 0.50 injuries per 100 full-time workers, compared with the hours-weighted average of 0.27 for the same 2-digit NAICS sector in OSHA ITA 2022–2023 filings. Our composite grade of "F" is that employer-to-sector ratio (A ≤0.5× sector · B ≤0.8× · C ≤1.2× · D ≤1.8× · else F), so a job seeker can compare a hospital chain to a warehouse or a bank to a food processor without chasing down OSHA formulas. Across all years on file, OSHA logged 55 reportable injuries at this employer.

For Regeneron Pharmaceuticals, Inc., the usable public record is dominated by H-1B labor-condition applications (51 on this profile) in Professional & Technical Services; those filings are sponsorship intent, not headcount, and cuts below the WARN threshold may never appear here.

OSHA Safety Record

Grade F DART Rate: 0.50 (same-NAICS-sector avg: 0.27)
This employer DART rate (lower is safer)
Same NAICS-sector average

Regeneron Pharmaceuticals, Inc.'s DART rate (days away/restricted/transferred per 100 FTE) vs the hours-weighted 2-digit NAICS sector average from OSHA ITA 2022–2023 (Professional & Technical Services).

Total reported injuries on file: 55.

How Regeneron Pharmaceuticals, Inc. compares to Professional & Technical Services peers

Regeneron Pharmaceuticals, Inc.'s nearest H-1B-filing peers in Professional & Technical Services (home state NY). Each card links to that employer's federal-records profile.

This employer

Professional & Technical Services · NY

Regeneron Pharmaceuticals, Inc.

51 H-1B filings
Median H-1B
$159,607
OSHA grade
F
WARN notices
0

Professional & Technical Services · TX

INFOSYS LIMITED

2,886 H-1B filings
Median H-1B
$102,937
OSHA grade
-
WARN notices
0

What to check before working with Regeneron Pharmaceuticals, Inc.

For Regeneron Pharmaceuticals, Inc., read sponsorship pay (51 H-1B LCAs, median $159,607) next to the OSHA safety grade (F).

  • H-1B median is $159,607 across 47 disclosed-wage positions (of 51 total filings), benchmark any offer against it and the metro prevailing wage. Compare with peers
  • Safety grade F reflects a DART rate read against the Professional & Technical Services average of 0.27 - a relative benchmark, not an absolute verdict. How grades work

Regeneron Pharmaceuticals, Inc.'s figures are legally filed public records (DOL, OSHA, state WARN), not reviews or vendor estimates; a missing row is not proof the underlying activity never happened.

Retrieved and formatted by PlainEmployers.

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from OSHA and the DOL Wage and Hour Division. Consult a qualified professional before making decisions based on this data.

Learn more: Safety Grades Explained | H-1B Salary Negotiation

This profile is rendered directly from DOL H-1B disclosure filings and OSHA Injury Tracking Application records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.